17:59:40 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-06-25 Årsstämma 2025
2025-03-05 Bokslutskommuniké 2024
2024-11-27 Kvartalsrapport 2024-Q3
2024-09-25 Kvartalsrapport 2024-Q2
2024-06-27 Ordinarie utdelning SOFTX 0.00 NOK
2024-06-26 Årsstämma 2024
2024-05-29 Kvartalsrapport 2024-Q1
2024-03-27 Extra Bolagsstämma 2024
2024-03-20 Bokslutskommuniké 2023
2023-10-26 Kvartalsrapport 2023-Q3
2023-09-26 Kvartalsrapport 2023-Q2
2023-06-21 Årsstämma 2023
2023-06-21 Kvartalsrapport 2023-Q1
2023-03-30 Ordinarie utdelning SOFTX 0.00 NOK
2023-02-17 Bokslutskommuniké 2022
2022-12-09 Extra Bolagsstämma 2022
2022-10-26 Kvartalsrapport 2022-Q3
2022-08-15 Kvartalsrapport 2022-Q2
2022-04-28 Kvartalsrapport 2022-Q1
2022-04-19 Ordinarie utdelning SOFTX 0.00 NOK
2022-04-17 Årsstämma 2022
2022-02-16 Bokslutskommuniké 2021
2021-12-29 Extra Bolagsstämma 2021
2021-11-17 Kvartalsrapport 2021-Q3
2021-09-08 Kvartalsrapport 2021-Q2
2021-04-29 Kvartalsrapport 2021-Q1
2021-04-14 Ordinarie utdelning SOFTX 0.00 NOK
2021-04-13 Årsstämma 2021
2021-02-09 Bokslutskommuniké 2020
2020-12-14 Kvartalsrapport 2020-Q3
2020-09-30 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning SOFTX 0.00 NOK
2020-06-30 Kvartalsrapport 2020-Q1
2020-06-30 Årsstämma 2020
2019-12-20 Extra Bolagsstämma 2019
2019-06-27 Årsstämma 2019
2019-06-03 Ordinarie utdelning SOFTX 0.00 NOK
2018-07-02 Split SOFTX 1:50

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriMedicinteknik
SoftOx Solutions är ett norskt medicintekniskt bolag. Bolaget har utvecklat en egenpatenterad lösning baserad på ättiksyra för behandling av kroniska sår hos patienter. Lösningen används för att eliminera infektioner i samband med biofilmer, vilket består av olika kluster av bakterier. En del av läkemedelsutvecklingen sker i samarbete med övriga forskningsinstitut. SoftOx Solutions etablerades under 2012 och har sitt huvudkontor i Oslo, Norge.
2018-12-21 17:04:26
Successful private placement
21 December 2018
Reference is made to the stock exchange release by SoftOx Solutions AS (the
“Company” or “SoftOx” with Merkur ticker: “SOFTOX-ME”) on 14 December 2018
regarding a contemplated private placement (the “Private Placement”) of new
shares in the Company.
SoftOx is pleased to announce that the Company has successfully completed a NOK
15 million Private Placement with the support from new and existing
shareholders. The Private Placement consists of 680 000 new shares, each at a
subscription price of NOK 22.
Completion of the Private Placement is subject to the adoption of the required
corporate resolutions of the Company, which will include a resolution by the
Company's extraordinary general meeting scheduled for 2 January 2019.
Notice of a conditional allocation conducted by the Board of Directors is
expected to be distributed to the investors on 22 December 2018.
The following primary insiders of the Company have been conditionally allocated
shares in the Private Placement:
•	Hermod Finans AS, a company fully owned by an affiliate of Geir Almås, Chief
Executive Officer: 91 000 shares. Geir Almås and affiliates controls after the
share issue 788,750 shares.
•	Dinge Invest AS, a company fully owned by Kristian Almås and family,
Non-executive member of the Board: 141 255 shares. Kristian Almås and affiliates
controls after the share issue 1,556,055 shares.
Completion of the Private Placement is also conditional upon the Offer Shares
having been fully paid and legally issued. Following issuance of the Offer
Shares, the Company will have an issued share capital of NOK 89 173 divided into
4,458,650 common shares, each with a nominal value of NOK 0,02. 
SpareBank 1 Markets AS acts as manager in the Private Placement. 

For further information, please contact:
Mr. Geir H. Almås, CEO, tel: +47 977 59 071, e-mail: geir.almaas@soft-ox.com